Vanguard Group
BVS icon

Vanguard Group’s Bioventus BVS Stock Holding History

Vanguard Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$22.2M Buy
2,984,927
+60,139
+2% +$432K ﹤0.01% 2573
2025
Q3 		$19.6M Buy
2,924,788
+122,749
+4% +$852K ﹤0.01% 2640
2025
Q2 		$18.5M Buy
2,802,039
+247,815
+10% +$1.76M ﹤0.01% 2592
2025
Q1 		$23.4M Buy
2,554,224
+92,143
+4% +$920K ﹤0.01% 2440
2024
Q4 		$25.9M Buy
2,462,081
+388,174
+19% +$4.59M ﹤0.01% 2463
2024
Q3 		$24.8M Buy
2,073,907
+413,241
+25% +$3.57M ﹤0.01% 2485
2024
Q2 		$9.55M Buy
1,660,666
+442,166
+36% +$2.43M ﹤0.01% 2956
2024
Q1 		$6.34M Hold
1,218,500
– – ﹤0.01% 3199
2023
Q4 		$6.42M Buy
1,218,500
+17,420
+1% +$68.9K ﹤0.01% 3185
2023
Q3 		$3.96M Buy
1,201,080
+5,668
+0.5% +$19.9K ﹤0.01% 3343
2023
Q2 		$3.45M Sell
1,195,412
-136,020
-10% -$261K ﹤0.01% 3466
2023
Q1 		$1.42M Sell
1,331,432
-14,899
-1% -$28.5K ﹤0.01% 3796
2022
Q4 		$3.51M Buy
1,346,331
+162,425
+14% +$709K ﹤0.01% 3455
2022
Q3 		$8.29M Buy
1,183,906
+191,671
+19% +$1.5M ﹤0.01% 3053
2022
Q2 		$6.77M Sell
992,235
-128,829
-11% -$1.31M ﹤0.01% 3202
2022
Q1 		$15.8M Sell
1,121,064
-435,365
-28% -$5.83M ﹤0.01% 2905
2021
Q4 		$22.6M Buy
1,556,429
+752,650
+94% +$10.7M ﹤0.01% 2772
2021
Q3 		$11.4M Buy
803,779
+286,286
+55% +$4.41M ﹤0.01% 3163
2021
Q2 		$9.11M Buy
517,493
+303,495
+142% +$4.89M ﹤0.01% 3256
2021
Q1 		$3.27M Buy
+213,998
New +$3.05M ﹤0.01% 3726

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Vanguard Group's BVS Position: Q4 2025 in Review

Vanguard Group increased its Bioventus (BVS) stake by 2.1% in Q4 2025, buying an estimated $432K and bringing the position to 2,984,927 shares worth $22.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Vanguard Group first reported a position in BVS in Q1 2021 and has held it in 20 quarters since. The position peaked at $25.9M in Q4 2024. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

  • Vanguard Group held 2,984,927 shares of Bioventus worth $22.2M as of Q4 2025.
  • Vanguard Group bought 60,139 Bioventus shares in Q4 2025, an estimated $432K.
  • Bioventus made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2573 holding.
  • Vanguard Group first reported a position in Bioventus in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Bioventus position peaked at $25.9M in Q4 2024.
  • 148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.